Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/6641
Title: Takayasu's arteritis in Turkey - Clinical and angiographic features of 248 patients
Authors: Bicakcigil, M.
Aksu, K.
Kamali, S.
Ozbalkan, Z.
Ates, A.
Karadag, O.
Ozer, H.T.E.
Keywords: Clinical and angiographic features
Prognosis
Takayasu's arteritis
azathioprine
corticosteroid
cyclophosphamide
leflunomide
methotrexate
mycophenolic acid 2 morpholinoethyl ester
tumor necrosis factor inhibitor
adult
aged
angiography
aorta arch syndrome
aorta valve regurgitation
appetite
arthralgia
arthritis
article
blurred vision
carotid artery
cerebrovascular accident
claudication
clinical feature
clinical protocol
controlled study
demography
disease classification
dyspnea
erythema nodosum
female
fever
follow up
headache
heart infarction
heart palpitation
human
hypertension
kidney artery stenosis
limb pain
major clinical study
male
pericarditis
priority journal
prognosis
prospective study
pulmonary hypertension
Raynaud phenomenon
remission
renal artery
subclavian artery
syncope
thorax pain
turkey (bird)
weakness
weight reduction
Adolescent
Adult
Age of Onset
Aged
Angiography
Child
Comorbidity
Drug Therapy, Combination
Female
Glucocorticoids
Humans
Immunosuppressive Agents
Male
Middle Aged
Prospective Studies
Remission Induction
Takayasu Arteritis
Turkey
Young Adult
Abstract: Objective. Takayasu's arteritis (TA) is a chronic, inflammatory vasculitis affecting the aorta and its major branches. Although it is more prevalent in Far-East Asia, the distribution of the disease is worldwide with different vascular involvement patterns and clinical manifestations. The objective of this study was to evaluate the demographic, clinical, angiographic and prognostic features of TA patients in Turkey. Methods. Clinical and angiographic findings of 248 TA patients (228 female, 27 male) followed at 15 Rheumatology Centers were prospectively evaluated according to a predefined protocol. Results. The mean age was 40.1 years (30.2 years at the clinical onset). Clinical manifestations included constitutional symptoms in 66%, absent or diminished pulses in 88%, bruits in 77%, extremity pain in 69%, claudication in 48%, hypertension in 43% and cerebrovascular accidents (CVA) in 18% of the patients. Renal artery stenosis, aortic regurgitation and pulmonary hypertension were present in 26%, 33% and 12%, respectively. According to the new angiographic classification, type V (50.8%) and Type I (32%) were the most frequent types of involvement. Corticosteroids were the main treatment in 93% of the patients alone (9%) or in combination with immunosuppressive agents (84%). Most frequently preferred immunosuppressive agents were methotrexate (63%), azathioprine (22%) and cyclophosphamide (13%). Remission was observed at least once in 94% of the patients and sustained remission in 71% during follow-up. Conclusion. The demographical, clinical and angiographic findings of TA patients in our series were similar to those reported from Japan, Brazil and Colombia. Combination therapies with immunosuppressive agents were the preferred choice of treatment in Turkey. © Copyright Clinical and Experimental Rheumatology 2009.
URI: https://hdl.handle.net/11499/6641
ISSN: 0392-856X
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

181
checked on Jun 29, 2024

WEB OF SCIENCETM
Citations

166
checked on Jul 2, 2024

Page view(s)

32
checked on May 27, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.